Pot Stocks Start 2019 With a Bang

Together with Grizzle, Civilized provides a weekly unique look at the growing cannabis market, in our cannabis sector investment show All Time Highs. Grizzle illuminates the opportunities and guides you through the challenges of this new sector, by identifying the opportunities and risks for the new industry, from a ‘big picture’ perspective to actionable, cash-generating ideas. 

This week, the President of Grizzle - Thomas George - discusses how cannabis stocks have been on a tear in 2019 as the industry keeps growing up. Heading in a different direction, whole flower prices are on a steady decline, but producers are getting more efficient manufacturing at scale, and retail prices for edibles and concentrates are holding steady. An analyst is also predicting the Canadian supply shortage will last up to three years, which Grizzle thinks will be resolved by the end of the year. For more answers on cannabis stocks and businesses, remember to send in your questions.


A new study shows that people suffering from anxiety may be able to successfully transition off of traditional medications to medical marijuana. Nearly half of participants in a recent study successfully stopped using benzodiazepines after beginning medical marijuana treatment. The study participants were made up of 146 anxiety patients.

Can we see some ID please?

You must be 19 years of age or older to enter.